CME
Latest Episodes
Wet AMD Pipeline Therapies Part 2: PDS and RGX-314
Host: Christina Y. Weng, MD, MBA Guest: Peter A. Campochiaro, MD In this video case discussion, Program Chair Christina Y. Weng, MD, MBA, and Peter A. Campochiaro, MD, review pipeline therapies for wet age-related macular degeneration. The f
Wet AMD: Pipeline Therapies Part 1 - Faricimab and OPT-302
Host: Christina Y. Weng, MD, MBA Guest: Diana Do, MD In this video case discussion, Program Chair Christina Y. Weng, MD, MBA, and Diana V. Do, MD, review pipeline therapies for wet age-related macular degeneration. Drs. Do and Weng assess ch
Primary Thromboprophylaxis of Patient at High-Risk of VTE Who Is Receiving Systemic Anticancer Therapy
Guest: Cihan Ay, MD There is not a one size fits all approach for managing cancer-associated venous thrombosis (CAT), as each patient reports unique challenges. In the face of multiple options to appropriately treat and manage CAT, thrombosis
Treatment of a Patient With Cancer and With Catheter-Related Thrombosis
Guest: Cihan Ay, MD There is not a one size fits all approach for managing cancer-associated venous thrombosis (CAT), as each patient reports unique challenges. In the face of multiple options to appropriately treat and manage CAT, thrombosis
Treatment of Patient With Low Risk of Gastrointestinal Absorption Impairment for Established VTE With Cancer
Guest: Jean M. Connors, MD There is not a one size fits all approach for managing cancer-associated venous thrombosis (CAT), as each patient reports unique challenges. In the face of multiple options to appropriately treat and manage CAT, thro
Treatment of Patient With Low Risk of Genitourinary Bleed for Established VTE With Cancer
Guest: Jean M. Connors, MD There is not a one size fits all approach for managing cancer-associated venous thrombosis (CAT), as each patient reports unique challenges. In the face of multiple options to appropriately treat and manage CAT, thro
Treatment of Patients With Established VTE With Cancer and COVID-19
Guest: Alok A. Khorana, MD There is not a one size fits all approach for managing cancer-associated venous thrombosis (CAT), as each patient reports unique challenges. In the face of multiple options to appropriately treat and manage CAT, thro
Prophylaxis of Medically Treated Patient With Cancer and Reduced Mobility in Hospital
Guest: Alok A. Khorana, MD There is not a one size fits all approach for managing cancer-associated venous thrombosis (CAT), as each patient reports unique challenges. In the face of multiple options to appropriately treat and manage CAT, thro
How Do We Make Sense of Guidelines and Apply to Our Everyday Practice?
Guest: Cihan Ay, MD Guest: Jean M. Connors, MD Guest: Alok A. Khorana, MD There is not a one size fits all approach for managing cancer-associated venous thrombosis (CAT), as each patient reports unique challenges. In the face of multi
Recent Advances and Emerging Approaches in the Treatment of Recurrent/Metastatic SCCHN: Matching the Patient to the Optimal Therapy
Host: Ezra Cohen, MD, FRCPSC, FASCO Guest: Petr Szturz, MD, PhD While key clinical trials inform our management philosophy for patients with recurrent/metastatic squamous cell carcinoma of the head and neck (R/M SCCHN), the paucity of predic
Visit Podcast Website
RSS Podcast Feed
Subscribe
Share
Add to MyCast